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Abstract
Background: With emphasis on policy implications, the main objective of this study was to estimate the numbers
of two main groups affected by FGM/C in Norway: 1) those already subjected to FGM/C and therefore potentially in
need for health care and 2) those at risk of FGM/C and consequently the target of preventive and protective measures.
Special attention has been paid to type III as it is associated with more severe complications.
Methods: Register data from Statistics Norway (SSB) was combined with population-based survey data on FGM/C in
the women/girls’ countries of origin.
Results: As of January 1st 2013, there were 44,467 first and second-generation female immigrants residing in Norway
whose country of origin is one of the 29 countries where FGM/C is well documented. About 40 pct. of these women
and girls are estimated to have already been subjected to FGM/C prior to immigration to Norway. Type III is estimated
in around 50 pct. of those already subjected to FGM/C. Further, a total of 15,500 girls are identified as potentially at risk,
out of which an approximate number of girls ranging between 3000 and 7900 are estimated to be at risk of FGM/C.
Conclusion: Reliable estimates on FGM/C are important for evidence-based policies. The study findings indicate that
about 17,300 women and girls in Norway can be in need of health care, in particular the 9100 who are estimated to
have type III. Preventive and protective measures are also needed to protect girls at risk (3000 to 7900) from being
subjected to FGM/C. Nevertheless, as there are no appropriate tools at the moment that can single these girls out of
all who are potentially at risk, all girls in the potentially at risk group (15,500) should be targeted with preventive
measures.
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Background
The World Health Organization (WHO) defines Female
Genital Mutilation/Cutting (FGM/C) as ‘all procedures
that involve partial or total removal of the external
female genitalia, or other injury to the female genital
organs for non-medical reasons’ [1]. FGM/C is associated
with series of immediate and long-term physical and psy-
chological health consequences [2–7].
It is estimated that 133,000,000 girls and women in 29
countries have undergone FGM/C, and that 3,600,000
girls are at risk annually [8]. Immigration from these
countries to other parts of the world has made FGM/C
a global concern. As a response, many governments in
host countries have established preventive, protective and
prosecutive measures alongside health care provision to
tackle the issue [9–21]. The target group for preventive
and protective measures is girls at risk, while health care
provision targets girls and women already subjected to the
procedure. Efficient planning and allocation of resources
for the different sets of measures require precise estimates
of total numbers of women and girls in each of the two
target groups.
Currently, the most accurate estimates on the preva-
lence of FGM/C and those at risk are derived from
population-based survey data such as Demographic
Health Survey (DHS) and Multiple Indicator Cluster
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Survey (MICS) in 29 countries where FGM/C is trad-
itionally practiced [22]. To employ similar methods in
diaspora, where FGM/C is only common among immi-
grant minorities, would be methodologically, ethically
and financially difficult. Therefore, alternative models
and data-sources have been explored. The most com-
monly used alternative model in Europe extrapolates
prevalence data from countries of origin to the corre-
sponding resident female immigrant population [23].
Other models include surveys among health professionals
[23–25] and non-representative samples of FGM/C prac-
ticing communities [23, 26, 27]. Even though the results
from these surveys cannot be generalized, it still provides
important insight into how FGM/C is evolving in the
diaspora.
In Norway, a previous risk estimate was published in
2008 by the Norwegian Institute for Social Research (ISF)
[28]. The estimate was a small part of a larger study that
focused on incidence of FGM/C and included only women
and girls between 0 and 19 years of age from six African
countries [28].
To give a more comprehensive estimate on the number
of women and girls in Norway living with FGM/C and
girls at risk of FGM/C we included in this study both first
and second generation immigrants from the 29 FGM/C
prevalent countries. An earlier and less refined version of
this study was published by DAMVAD and NKVTS in
2014 [29]. The earlier version did not take into account
differences in prevalence when estimating the number of
girls at risk for FGM/C; neither did it include data on typ-
ology. The present paper controls for both these factors,
as well as employing updated national prevalence data.
Methods
We adopted the extrapolation model to estimate the num-
ber of girls and women living in Norway by January 1st
2013 who were at risk of FGM/C and those who most likely
already have been subjected to FGM/C. We combined data
on FGM/C from the 29 FGM/C prevalent countries with
register data on first- and second-generation female immi-
grants from these countries.
Methodological approaches
In 2012, a consortium of researchers were commissioned
by the European Institute for Gender Equality (EIGE) to
map the current situation on FGM/C in the European
Union (EU) and Croatia [30]. The study identified lack
of harmonized approach to generate reliable data on the
magnitude of FGM/C as one of the main challenges
facing the development of effective policies on FGM/C
in the EU [23, 30]. The study also found that even when
the extrapolation model was adopted, the variation in
definitions and data sources have generated incompar-
able data [23, 30].
To enhance the comparability of our findings with other
study findings in the region, we have therefore adhered as
close as possible to the definitions, models and methodo-
logical approaches recommended by the aforementioned
consortium of researchers in their 2103 [30] and 2015 [31]
reports, as well as other key articles [23, 32, 33].
The extrapolation model combines prevalence data from
countries of origin with data on resident population in the
diaspora with origins from these countries [23]. So far
national prevalence rates have been predominantly used in
prevalence studies using this model [23] with the excep-
tion of a Dutch study [33]. One of the limitations of using
national prevalence rates is that it obscures the variation
in prevalence levels among different ethnicities and/or
regions in the different countries [22, 23, 33]. Not adjust-
ing for ethnicity could lead to bias in form of under- or
over- estimation. In most European countries, including
Norway, the National Registry offices do not provide infor-
mation on ethnicity for ethical and legal reasons [23].
Nevertheless, as there is a close correlation between
ethnicities and sub-regions within countries of origin [22],
adjusting for regional differences could be a viable alterna-
tive [23]. A study carried out in the Netherland has there-
fore used data on places of birth to regroup the female
immigrants according to regions within their countries of
origin [33]. In Norway, additional data on place of birth
could be requested from Statistics Norway. Unfortunately,
since this recommendation was first published after we
had requested and acquired our dataset, we were unable
to adjust for neither ethnicity nor regional differences.
This could therefore lead to a possible bias in our results
in the form of under- or over- estimation. This bias could
still be insignificant for countries with small numbers of
immigrants and countries of high national prevalence.
However, for countries with low national prevalence but
larger immigrant groups such bias is more likely to affect
the overall estimate. In this study Iraq is such an ex-
ample. The national prevalence of FGM/C in Iraq is
8 pct. whereas it is as high as 42.8 pct. among the
Kurdish population. According to estimates from the
Norwegian office of immigration (UDI), a little over
40 pct. of the Iraqi residents in Norway are of Kurdish
origin. If this factor is taken into account, the total num-
ber of Iraqis affected by FGM/C in Norway will be much
higher than our current estimates.
Another limitation of the extrapolation of national
prevalence level is that it does not address the selection
process of immigrants [32]. Ortensi et al. [32] argue that
migration is a selective process and that immigrants are
usually younger, wealthier, and more educated than their
counterpart that did not migrate. Since younger age and
higher levels of wealth and education often are corre-
lated with lower prevalence levels of FGM/C, the au-
thors emphasize that the application of the national
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prevalence levels without adjustment for age, wealth and
education is likely to bias the indirect estimates of FGM/
C prevalence [32]. Again, it was unfortunate that this
recommendation was published after finalization of the
data analysis and subsequent deletion of dataset (strati-
fied by age) as stipulated by Statistics Norway. The sug-
gested improved model will nevertheless be
incorporated in any future follow-up studies.
Prevalence estimation
Leye et al. [23] defined the prevalence of FGM/C in
any EU member state as ‘the number of women and
girls in that country who have undergone FGM at a
certain point in time expressed as the proportion of
the total number of women living in the country, but
originating from countries where FGM is practiced’.
In this article, we adopted a similar definition for
the prevalence of FGM/C in Norway: The proportion
of girls and women estimated to have undergone
FGM/C at a certain point in time out of the total
number of women and girls with origins from the 29
FGM/C prevalent countries.
Identifying the relevant populations and sub-
populations is central to both prevalence and risk esti-
mation of FGM/C. The total resident population origin-
ating from the 29 FGM/C prevalent countries in
Norway consists of first- and second-generation immi-
grants. In this article, we use the term first- generation
immigrants to refer to girls and women who migrated
from one of the 29 countries where FGM/C is concen-
trated, whereas second- generation immigrants refers
to girls born in Norway to two parents who have mi-
grated from one of these 29 countries. Girls with only
one parent from a FGM/C practicing country were ex-
cluded, as the risk is very uncertain and most likely
low.
The first-generation immigrants consist of those who
have been subjected to FGM/C prior to arrival in host
countries, those who have been subjected to FGM/C
post arrival, those who have not been subjected to FGM/
C because they/their families do not practice or have
abandoned the practice, and those who have not been
subjected to FGM/C but still are at risk.
The second-generation group consists of those who
have been subjected to FGM/C at one point of time, those
who have not been subjected to FGM/C and are not at
risk as their families do not practice or have abandoned
the practice and those who have not been subjected to
FGM/C but still at risk.
Thus the relevant groups for estimation of FGM/C
prevalence would be:
1) First-generation immigrants who have been
subjected to FGM/C prior to arrival in host
countries and those who have been subjected
to FGM/C post arrival.
2) Second-generation immigrants who have been
subjected to FGM/C at one point of time.
In countries of origin, there is usually a customary age
within which FGM/C is performed [22]. Thus, it would
be safe to assume that those of first-generation immi-
grants who were older than that age upon arrival in host
countries, had already been subjected to FGM/C in cor-
responding proportion to the prevalence rates in their
countries of origin.
The challenge would be to estimate the number of
second-generation immigrants who have been subjected
to FGM/C, as well as those of the first-generation immi-
grants who have been subjected to FGM/C post migration
(those who were younger than the customary age upon
arrival but older than that age by the time of analysis/
estimation). This challenge arises from the lack of reli-
able FGM/C incidence rates in host countries and the
expected overestimation if extrapolation of prevalence
rates from countries of origin were to be used. There is
growing evidence on attitude change toward FGM/C in
host countries that would indicate FGM/C is practiced
at much lower rates than in countries of origin [34–37].
Therefore, we have decided to assume that none of the
first-generation immigrants who were younger than the
customary age of FGM/C in their countries of origin
upon arrival in Norway or the second-generation immi-
grants has been subjected to FGM/C.
FGM/C risk estimation
The 2015 EIGE report [31] emphasized the difference
between girls potentially at risk and girls at risk.
Girls potentially at risk are defined as ‘minor girls (in the
age range of 0–18) who come from FGM risk countries, or
were born to parents (or one parent) who originate from
countries where female genital mutilation is commonly
practiced’ [31]. We found it necessary to modify this def-
inition as including all first-generation girls under the age
of 18 would imply including girls who could already have
been subjected to FGM/C prior to migration. As a conse-
quence we considered only first-generation girls who were
younger upon arrival in Norway than the customary age
of FGM/C in their countries of origin to be potentially at
risk; whereas for second-generation girls, all those under
18 were considered to be potentially at risk. Further for
the second-generation girls, only those with BOTH par-
ents originating from one of the 29 countries were in-
cluded. Therefore it is more apt to say that our definition
for girls potentially at risk is: ‘first-generation girls who
were younger upon arrival in Norway than the customary
age for FGM/C in their countries of origin and second-
generation girls who at the time of data collection
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(reference year/date) were younger than 18’. Preventive
measures should target all girls potentially at risk.
On the other hand, girls at risk is not defined per se in
the 2015 EIGE report [31]. Instead the report provides a
definition for the FGM/C risk estimation as:
‘minor girls (either born in, or born to mothers from,
FGM risk countries) living in an EU Member State who
might actually be at risk of female genital mutilation,
expressed as a proportion of the total number of girls
living in an EU country who originate from or are born
to a mother from FGM risk countries’ [31].
The corresponding recommended model presents
the risk estimation as an interval between low and
high risk scenarios that takes into consideration the
effect of migration through ‘migration and accultur-
ation impact factor’ [31]. In this model the national
FGM/C prevalence rate for the age cohort 15–19 is
multiplied by the total number of first and second
generation immigrant girls who are younger than the
customary age for cutting at their/their parents coun-
tries of origin. Here, unlike the estimation of girls po-
tentially at risk, the customary age for cutting is
taken into consideration. We do agree that the cus-
tomary age for FGM/C in the countries of origin is
important to exclude first-generation girls who could
have been subjected to FGM/C prior to migration.
However, we are skeptical to the exclusion of first-
generation girls who have been younger than the custom-
ary age in their countries of origin upon arrival but older
than that age at the time of data collection/reference year.
The same applies to second-generation girls who were
older than the customary age. This skepticism stems from
the emerging evidence that customary age for cutting in
countries of origin has less relevance in the migration
context, where the ‘opportunity to cut’ seems to be more
significant [31]. Consequently, we have only excluded
first-generation girls who were older than the customary
age upon arrival, first-generation girls who were younger
than the customary age upon arrival but older than 18 at
the reference year, and second generation girls who were
also older than 18 at the reference year.
Other than this modification on the exclusion criteria,
we have followed the rest of the steps described in the
recommended model.
The recommended model expresses the migration and
acculturating impact factor as binary variable with values
as either ‘0’ or ‘1’ and is assessed through qualitative
research. The ‘0’ value signifies that migration has no
impact on attitudes and behaviors toward FGM/C in the
migration context. That is to say that the risk of FGM/C
would be the same as if migration never took place. The
‘1’ value signifies on the other hand that migration
has such an impact on attitudes and behaviors toward
FGM/C that the level of risk is reduced to zero.
In the high FGM/C risk scenario, it is assumed that
migration has no effect whatsoever (migration and ac-
culturation impact factor equal ‘0’) and that the number
of first and second generation girls at risk of FGM/C
would be the same as if they/their parents have never
migrated [31].
In the low FGM/C risk scenario, it is assumed that
migration has an impact on attitudes and behaviors









Benin 7,3 % 2,0 % 0–14 DHS 2011–
12
Burkina Faso 75,8 % 57,7 % 0–4 DHS 2010
Cameroon 1,4 % 0,4 % 5–9 DHS 2004
Central African
Republic
24,2 % 17,9 % 5–14 MICS 2010
Chad 44,2 % 41,0 % 0–9 MICS 2010
Côte d’Ivoire 38,2 % 31,3 % 0–5 DHS 2012
Djibouti 93,1 % 89,5 % 5–9 MICS 2006
Egypt 97,0 % 98,1 % 10–14 DHS 1995
Eritrea 88,7 % 78,4 % 0–2 DHS 2002
Ethiopia 74,3 % 62,1 % 0–2 DHS 2005
Gambia 76,3 % 77,1 % 0–4 MICS 2010
Ghana 3,8 % 1,5 % 4–14 MICS 2011
Guinea 96,9 % 94,0 % 0–9 MICS 2012
Guinea–Bissau 49,8 % 48,4 % 0–9 MICS 2010
Iraq 8,1 % 4,9 % 4–10 MICS 2011
Kenya 27,1 % 14,6 % 5–14 DHS 2008–
09
Liberia 58,3 % 35,9 % 10–15 DHS 2007
Mali 91,4 % 90,3 % 0–4 DHS 2012–
13
Mauritania 69,4 % 65,9 % 0–4 MICS 2011
Niger 2,0 % 1,4 % 0–3 DHS 2012
Nigeria 24,8 % 15,3 % 0–3 DHS 2013
Senegal 25,7 % 24,0 % 0–4 DHS 2010–
11
Sierra Leone 89,6 % 74,3 % 8–18 DHS 2013
Somalia 97,9 % 96,7 % 5–9 MICS 2006
Sudan 89,2 % 86,8 % 6–8 DHS 1989–
90
Togo 3,9 % 1,1 % 4–14 MICS 2010
Uganda 1,4 % 1,0 % 8–18 DHS 2011
United Republic
of Tanzania
14,6 % 7,1 % 0–5 DHS 2010
Yemen 22,6 % 19,3 % 0–1 DHS 1997
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toward FGM/C and that second-generation girls experi-
ence a lower risk. In contrast, the first-generation girls
are considered to be at risk (migration and acculturation
impact factor equal ‘0’). Even though for purposes of cal-
culation the migration and acculturation impact factor
for second-generation girls in this scenario is given the
value ‘1’, the authors caution against interpreting this es-
timation in the strictest sense that no second-generation
girl would be at risk [31].
The resulting estimates of the low and high risk scenar-
ios are then presented as an interval; in which the esti-
mates from the two scenarios demarcate its boundaries.
The scenario that is more likely to apply in the local con-
text is finally selected according to the findings from the
qualitative component [31]. We have not carried out a
qualitative study as recommended to accompany our
estimation analysis. Still, there are several recent studies
on change of attitude and behavior among Somalis in
Norway [34–36] that helped to guide us as to which of the
two scenarios is more relevant.
Finally, it is important to mention that despite the
great potential of this model, the binary nature of the
migration and acculturation impact factor is a significant
limitation. To assume that migration would have either
‘no impact’ or ‘a huge impact’ on attitudes and behaviors
towards FGM/C is in contrast to findings from several
studies that indicate much more fluid opinions and varia-
tions in the depth or intensity of conviction [22, 38–41].
The migration and acculturation impact factor can be
significantly improved by future research that can help to
Table 2 DHS and MICS data: prevalence of different types of FGM/C
Country Prevalence level 15–49 Prevalence level 15–19 Data source
Type 3 Other types or undetermined Type 3 Other types or undetermined
Benin 12,5 % 87,5 % 8,7 % 91,3 % DHS 2011–12
Burkina Faso 1,2 % 98,8 % 0,7 % 99,3 % DHS 2010
Cameroon 5 % 95 % 5 % 95 % DHS 2004
Central African Republic 7 % 93 % 9,5 % 90,5 % MICS 2010
Chad 7,2 % 92,8 % 8,3 % 91,7 % MICS 2010
Côte d’Ivoire 8,7 % 91,3 % 10,4 % 89,6 % DHS 2011–12
Djibouti 67,2 % 32,8 % 42,4 % 57,6 % MICS 2006
Egypt 0,7 % 99,3 % 2,3 % 97,7 % DHS 1995
Eritrea 38,6 % 61,4 % 33,8 % 66,2 % DHS 2002
Ethiopia 6,1 % 93,9 % 4,7 % 95,3 % DHS 2005
Gambia 8,9 % 91,1 % 6,6 % 93,4 % MICS 2010
Ghana 8 % 92 % 6,7 % 93,3 % MICS 2011
Guinea 7,5 % 92,5 % 7,7 % 92,3 % MICS 2012
Guinea-Bissau 11,8 % 88,2 % 11,4 % 88,6 % MICS 2010
Iraq 0 % 100 % 0 % 100 % MICS 2011
Kenya 13,4 % 86,6 % 17,6 % 82,4 % DHS 2008–09
Liberia 0 % 100 % 0 % 100 % DHS 2007
Mali 10,6 % 89,4 % 11,1 % 88,9 % DHS 2012–13
Mauritania 0 % 100 % 0 % 100 % MICS 2011
Niger 6,3 % 93,7 % 8,0 % 92,0 % DHS 2012
Nigeria 5,3 % 94,7 % 3,6 % 96,4 % DHS 2013
Senegal 13,8 % 86,2 % 10,9 % 89,1 % DHS 2010–11
Sierra Leone 9,0 % 91,0 % 10,1 % 89,9 % DHS 2013
Somalia 79,3 % 20,7 % 76,0 % 24,0 % MICS 2006
Sudan 82,3 % 17,7 % 73,9 % 26,1 % DHS 1989–90
Togo 5,1 % 94,9 % 0 % 100 % MICS 2010
Uganda 0 % 100 % 0 % 100 % DHS 2011
United Republic of Tanzania 0,7 % 99,3 % 0,8 % 99,2 % DHS 2010
Yemen 0 % 100 % 0 % 100 % DHS 1997
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assign values between ‘0’ and ‘1’ dependent on scores
given to identified determinants for change.
Estimation of type III
We extrapolated the prevalence of the different types of
FGM/C in countries of origin to the different groups to
estimate the number of those expected to have already
been subjected to the most severe form of FGM/C
(infibulation) and those at risk of infibulation.
Data sources
In this study, we used two main data sources: 1) DHS
and MICS and 2) Statistics Norway (SSB).
DHS and MICS are broad population and health surveys
using a statistically representative sample of the popula-
tion. In both DHS and MICS surveys, the percentage of
girls and women aged 15 to 49 reporting to have experi-
enced any form of FGM/C is used to indicate how preva-
lent the practice is in a particular country [22]. Great
consistency of data over time, as well as comparability to
other studies, suggest that data on national prevalence is
reliable [22, 42]. Still, it is important to acknowledge some
of the inherent limitations of the DHS and MICS surveys
such as reporting bias and the inability to reflect recent
FGM/C trends in practicing countries [26, 32].
The DHS and MICS data used in this article are openly
available and are published online in form of country re-
ports on the respective web-sites for the responsible orga-
nizations. We used the most recent DHS and MICS
reports for each of these 29 countries [43, 44] to ensure
that we have the latest data on prevalence, typology and
customary age for FGM/C (Tables 1 and 2). In two coun-
tries, Egypt and Sudan, the latest reports (DHS 2008 and
MICS 2010 respectively) did not provide information on
typologies. For these two countries we instead used data
from the latest available report that has information on
typology, e.g. for Egypt we used the DHS 1995 instead of
DHS 2008.
Data on the most extensive form of FGM/C, type III,
(Table 2) was available for most of the countries with a
Table 3 Statistic Norway dataset on first and second generation immigrants from the 29 countries by groups
Country Group 1 Group 2 Total
Group 1a Group 1b Group 1c Group 2a Group 2b
Cameroon 204 11 a 34 0 257
Côte d’Ivoire 99 11 a 15 a 127
Djibouti 30 a a 10 a 46
Egypt 203 30 42 44 a 326
Eritrea 4508 218 10 606 107 5449
Ethiopia 2707 143 a 528 52 3434
Gambia 432 21 a 151 47 654
Ghana 582 133 47 226 62 1050
Guinea 73 29 a 17 a 127
Iraq 7285 1949 416 3422 146 13218
Kenya 643 120 64 50 17 894
Liberia 310 100 40 74 a 526
Nigeria 529 42 a 142 27 749
Senegal 71 a a 22 a 102
Sierra Leone 138 54 37 49 10 288
Somalia 8873 1630 593 3654 206 14956
Sudan 640 78 116 134 a 977
Togo 38 a a 14 0 62
Uganda 311 124 44 39 16 534
United Republic of Tanzania 340 42 8 36 a 432
Yemen 135 a 0 38 a 186
Other countriesb 51 a a 19 a 73
Total 28202 4763 1456 9324 722 44467
% 63 % 11 % 3 % 21 % 2 % 100 %
aMore than 0 and less than 10 per category
bCountries with less than 20 in total: Benin, Burkina Faso, Central African Republic, Chad, Guinea-Bissau, Mali, Mauritania and Niger
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large immigrant group in Norway. However, typology
data are missing for Liberia, Iraq, Uganda and Yemen.
Therefore we assumed a zero prevalence of type III in
these four countries. Generally, available data on types
of FGM/C is found to be much less reliable than prevalence
data, with a tendency to under-report type III [45, 46].
The dataset for this study was requested and obtained
from our second data source i.e. Statistics Norway (SSB)
which provides micro-data for research projects. Using
this dataset required exemption from the duty of confi-
dentiality and was further handled with utter adherence
to SSB ethical requirements. The dataset is population
register data that covers all female residents in Norway
that, by the reference date (January 1st 2013), have
migrated or their parents have migrated from one of
the aforementioned 29 countries (Table 3). This in-
cludes refugees, whereas women and girls visiting
Norway for less than six months, asylum seekers and
illegal immigrants are not included. The dataset includes
information on countries of origin, age at arrival in
Norway and current age. It also comprises information
on parents’ countries of origin for second-generation
immigrants.
Data analysis
As of 1st January 2013 there were 44,467 girls and
women who have either immigrated or their parents
have immigrated from one of the 29 FGM/C prevalent
countries (Table 3). We first divided these 44,467 girls
and women into two main groups: 1) first-generation
immigrants and group 2) second-generation immigrants.
We further divided the first group into three groups (1a,
1b and 1c) taking into account the following variables:
customary age for FGM/C in the country of origin, age at
arrival in Norway and current age.
Group 1a consisted of 28,202 girls and women who
upon arrival in Norway were older than the customary
age for FGM/C in their countries of origin (Table 3). Hence,
a corresponding proportion to the 15–49 prevalence rates
in countries of origin is most likely to have already been
subjected to the practice.
Group 1b consisted of 4763 girls who upon arrival in
Norway were younger than or within the customary age
for FGM/C in their countries of origin, and who by 1st
January 2013 were older than the customary age but youn-
ger than 18. Group 1c, consisted of 1456 girls who upon
arrival in Norway were younger than or within the cus-
tomary age for FGM/C in their countries of origin, and
who were still within the customary age or younger by
January 1st 2013. Both groups were assumed not to have
been subjected to FGM/C. Instead, these two groups were
considered to be potentially at risk, and that a proportion
of this group corresponding to that of girls in countries of
origin in the age group 15–19, are at risk of FGM/C.
Group 2, second-generation girls constituted 10,046
girls of which 9324 (group 2a) were under the age of 18
by January 1st 2013. We assumed that girls under 18
with both parents originally from one of the 29 countries
(9324) were potentially at risk and that a proportion of
this group corresponding to that of girls in countries of
origin in the age group 15–19 are at risk of FGM/C. In
limited cases where parents were from two different
FGM/C practicing countries, subsequent estimation was
based on prevalence levels from the mother’s country of
birth. Girls with only one parent from FGM/C practicing
country were excluded, as the risk is very uncertain and
most likely low.
To calculate the total number of girls potentially at
risk, we combined group 1b, 1c and 2a without adjusting
for prevalence rates in their parents’ countries of origin.
To estimate the FGM/C risk we adopted the EIGE
model described earlier in this section.



























% of the total FGM/C affected population 38.9 %
aAdjusted for prevalence level 15–49
bMore than 0 and less than 10 per category
cCountries with less than 20 in total: Benin, Burkina Faso, Central African
Republic, Chad, Guinea-Bissau, Mali, Mauritania and Niger
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Finally, to estimate the number of those who have
already been infibulated and the number of girls at risk
of infibulation, we extrapolated the prevalence of the
different types of FGM/C as reported in DHS and MICS
(Table 2) to the different groups.
Results
In this study we have divided girls and women into three
major categories: 1) first- and second- generation girls
and women who most likely have been subjected to
FGM/C prior to immigration, 2) first- and second-
generation girls who are potentially at risk of FGM/C,
and 3) first- and second- generation girls that are at
risk of FGM/C.
As of January 1st 2013, around 17,300 girls and women
are estimated to have already been subjected to FGM/C
prior to immigration to Norway, constituting an approxi-
mate prevalence of 40 pct. (Table 4). 50 pct. of these
17,300 girls and women originate from Somalia (Fig. 1).
Also, around 50 pct. of the 17,300 girls and women are es-
timated to have been infibulated (Table 5). The majority
of those estimated to be infibulated originate from
Somalia, Eritrea, Sudan and Ethiopia (Fig. 2). These num-
bers nevertheless need to be interpreted with caution as
data on types are significantly less reliable than prevalence
data.
On the other hand, 15,500 girls are estimated to be po-
tentially at risk (Table 6), while an approximate number of
girls ranging between 3000 and 7900 were estimated to be
at risk (Table 7). Finally, out of the total number of girls at
risk, a number of girls ranging between 1800 and 4800 are
estimated to be at risk of infibulation (Table 8).
Discussion
FGM/C prevalence and risk estimations are needed to
guide effective policies and interventions on health care
and prevention. Prevalence and risk estimates can help to
adjust the allocation of resources to the actual needs, as
well as to evaluate the results of various interventions.
Women and girls who have been subjected to FGM/C
(estimated to be around 17,300 in this study) are in
potential need of health care for related physical and
psychological complications. Need for health care is
expected to be particularly important for those who
have undergone infibulation (approximately 9100 out
of the 17,300). Prevalence estimates, together with data on
service provision and utilization, could also be useful in
the assessment of accessibility and acceptability of avail-
able services.
Risk estimates are necessary to guide preventive mea-
sures. Generally, the main objective of preventive measures
is to prevent FGM/C among girls at risk, who we found in
Fig. 1 FGM/C Percentage of girls and women already subjected to FGM/C in Norway by country of origin
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this study to be in the range of 3000 to 7900. Currently,
there are no appropriate tools, such as prediction models,
that can single out these girls from all who are potentially
at risk. Therefore, all girls who are potentially at risk,
15,500 girls, are to be targeted with preventive measures.
Still additional protective measures may be needed for the
girls at risk. Further, when combined with incidence rates,
estimates of girls at risk can be useful in the evaluation of
preventive measures and assessment of change.
Prevalence and risk estimates can also help to compare
the magnitude of FGM/C between different countries.
Currently, there are about 16 studies from nine European
countries that estimate the FGM/C prevalence and/or
risk by extrapolating DHS and MICS data to their
immigrant population [23, 32, 47]. However, beside
Norway, only three other countries use register-based
data (Italy, Netherlands and Belgium) which would lead to
more accurate estimates [23, 32, 33, 48]. The rest rely on
census data, that collect information on country of origin
Table 5 Girls and women already subjected to FGM/C by types
Country Already subjected to FGM/C
Type III Other types Total
Cameroon 0 a a
Côte d’Ivoire 3 35 38
Djibouti 19 9 28
Egypt a 196 197
Eritrea 1543 2456 3999
Ethiopia 123 1888 2011
Gambia 30 300 330
Ghana a 20 22
Guinea a 66 71
Iraq 0 590 590
Kenya 23 151 174
Liberia 0 181 181
Nigeria a 124 131
Senegal a 15 18
Sierra Leone 11 113 124
Somalia 6889 1798 8687
Sudan 470 101 571
Togo 0 a a
Uganda 0 a a
United Republic of Tanzania 0 49 49
Yemen 0 31 31
Other countriesb a 19 21
Total 9131 8150 17281
% 52.8 % 47.2 % 100 %
aMore than 0 and less than 10 per category
bCountries with less than 20 in total: Benin, Burkina Faso, Central African
Republic, Chad, Guinea-Bissau, Mali, Mauritania and Niger
Fig. 2 Numbers of girls and women subjected to FGM/C type III by
most represented countries of origin
Table 6 Girls potentially at risk
Country Group 1 Group 2 Total
Group 1b Group 1c Group 2a
Cameroon 11 a 34 53
Côte d’Ivoire 11 a 15 27
Djibouti a a 10 13
Egypt 30 42 44 116
Eritrea 218 10 606 834
Ethiopia 143 a 528 675
Gambia 21 a 151 175
Ghana 133 47 226 406
Guinea 29 a 17 52
Iraq 1949 416 3422 5787
Kenya 120 64 50 234
Liberia 100 40 74 214
Nigeria 42 a 142 193
Senegal a a 22 30
Sierra Leone 54 37 49 140
Somalia 1630 593 3654 5877
Sudan 78 116 134 328
Togo a a 14 24
Uganda 124 44 39 207
United Republic of Tanzania 42 8 36 86
Yemen a 0 38 46
Other countriesb a a 19 26
Total 4763 1456 9324 15543
% 11 % 3 % 21 % 100 %
aMore than 0 and less than 10 per category
bCountries with less than 20 in total: Benin, Burkina Faso, Central African
Republic, Chad, Guinea-Bissau, Mali, Mauritania and Niger
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from about five percent of the citizens, to estimate their
female population originating from FGM/C prevalent
countries [23]. Limitation of census data in such a context
is that uneven residence patterns of migrants in most
countries, and other challenges such as language barriers
or resistance to participation, can give inaccurate numbers
of residents.
It is not possible to directly compare our prevalence
estimates to that in other European countries. That is as
even when the extrapolation model is used, there is a
wide variation regarding who is included. In a recent
study from the UK, all female 15 years of age and above
emigrating from FGM/C prevalent countries were consid-
ered to have already undergone FGM/C in proportion to
the 15–49 prevalence in home countries [47]. In Belgium,
all immigrants, regardless of age upon arrival, are consid-
ered to have FGM/C but in proportion to the prevalence
in countries of origin [48]. The closest to our approach is
a recent study from the Netherlands. In the Dutch study,
all immigrant females who upon arrival were above the
median age for FGM/C in their home countries were
considered to have already been cut, but in proportion to
the corresponding age cohort [33]. In our study instead of
using median age as in the Dutch study, we used the
upper margin of the customary age as a cut-off point.
Comparing estimates of girls at risk is even more com-
plex. Even though only few European countries have
estimates on FGM/C risk so far, the variation in the
definition of who is at risk is vast. Second-generation is
considered to be at risk in proportion to the prevalence
in parents’ country of origin in Belgium [48]. In UK, it is
the first-generation under 15 that is considered as at risk
[47]. In the Netherlands, there are three alternative esti-
mates for girls at risk. Two out of the three alternatives
consider the second-generation to be at no risk [33].
Table 7 Estimated numbers of girls at risk of FGM/C: low and
high risk scenarios
Country At risk of FGM/C
Low FGM risk scenarioa High FGM risk scenariob
Cameroon 0 0






















Other countriesd c 12
Total 2999 7929
aGroup 1b + 1c adjusted for prevalence level 15–19
bGroup 1b + 1c + 2a adjusted for prevalence 15–19
cCountries with less than 20 in total: Benin, Burkina Faso, Central African
Republic, Chad, Guinea-Bissau, Mali, Mauritania and Niger
Table 8 Girls at risk of different types of FGM/C
Country Low FGM/C risk scenario High FGM/C risk scenario
Type III Other types Type III Other types
Cameroon 0 0 0 0
Côte d’Ivoire 0 a a a
Djibouti a a a a
Egypt a 69 a 111
Eritrea 60 118 221 433
Ethiopia a 87 20 399
Gambia a 17 a 126
Ghana 0 a 0 a
Guinea a 30 a 45
Iraq 0 116 0 284
Kenya a 22 a 28
Liberia 0 50 0 77
Nigeria 0 a a 28
Senegal 0 a a a
Sierra Leone a 61 11 94
Somalia 1634 516 4319 1364
Sudan 124 44 210 74
Togo 0 0 0 0
Uganda 0 a 0 a
United Republic
of Tanzania
0 a 0 a
Yemen 0 a 0 a
Other countriesb 0 a a a
Total 1842 1157 4811 3118
% 61 % 39 % 61 % 39 %
aMore than 0 and less than 10 per category
bCountries with less than 20 in total: Benin, Burkina Faso, Central African
Republic, Chad, Guinea-Bissau, Mali, Mauritania and Niger
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In addition, in this study we decided to include only
girls whose both parents are from countries with a trad-
ition of FGM/C. In contrast, most other studies include
all girls, even those with only one parent from FGM/C
prevalent countries [33, 47, 48]. We believe that our ap-
proach gives more accurate estimates, as the risk is ex-
pected to be significantly lower when one of the parents is
from a non-practicing country.
Nevertheless, the results from the three recent studies
from Ireland, Sweden and Portugal that have piloted the
recommended model for risk estimation presented in
the 2015 EIGE report [31] could, to some degree, be
comparable to our findings. In Ireland, the girls poten-
tially at risk in 2012 were 14,577, of which 70 pct. origi-
nated from Nigeria (a low prevalent country). Of these
girls the number estimated to be at risk varied between
158 and 1632. In Norway, the estimates for girls poten-
tially at risk in 2013 were very close to the estimates
from Ireland (15,500). Nevertheless in the high risk sce-
nario we can see a substantial difference between those
expected to be at risk in Ireland (1632) and their coun-
terpart in Norway (7900). A similar difference can also
be observed between our study and those from Sweden
and Portugal. In Sweden, 59,409 girls were potentially at
risk in 2011. Of these girls the number estimated to be
at risk varied between 2016 and 11,145. This substantial
difference, between our estimates and those of the EIGE
model’s pilot countries, can be attributed to the differ-
ence in the composition of the potentially at risk groups
in the different countries. Unlike Ireland and Portugal, a
large number of girls in Norway have origins from high
prevalence countries such as Somalia, Eritrea and Ethiopia.
The difference can also be attributed to the different inclu-
sion criteria for both the potentially at risk and the at risk
groups in our analysis and in the EIGE model. In our
analysis, unlike the EIGE model, girls under 18 who upon
arrival were older than the customary age in their countries
of origin were excluded from the potentially at risk. This
group was only excluded in the EIGE model while estimat-
ing the numbers of girls at risk. Further, we did not exclude
from our estimates of girls at risk those under 18 who were
older than the customary age for FGM/C in countries of
origin per the reference year. Instead, taking as a point of
departure the emerging evidence that ‘opportunity to cut’
is more relevant in countries of migration [31], we included
in our estimation all second-generation girls under 18, as
well as first-generation girls under 18 who were younger
than the customary age for FGM/C upon arrival.
The three above mentioned studies had an accompany-
ing qualitative component to assess change in attitudes
and behaviors toward FGM/C among the affected groups
following immigration. All three studies reported to find
change and consequently concluded that the estimates in
the low FGM/C risk could be more accurate [31]. We
have not conducted the recommended qualitative com-
ponent. Still, there are several recent studies that have
assessed attitudes and behaviors towards FGM/C among
Somalis in Norway [34–36]. The reported change in these
studies would indicate that similar to Ireland, Portugal
and Sweden, the estimates in the low FGM/C risk scenario
could be more accurate.
Conclusion
Reliable estimates on FGM/C are important for evidence-
based policy making. Thus in the absence of population
based representative surveys, the extrapolation model is
currently the most viable way to estimate both prevalence
and risk in diaspora.
In this study we aspired to estimate the number of two
main groups with different policy implications: those
who are already subjected to FGM/C and those at risk.
We calculated the number of girls and women who
are expected to have already undergone FGM/C. Also,
as type III is associated with higher health risks and
health care needs, we identified the proportion of those
expected to be infibulated. Our estimate suggests that
around 50 pct. of the 17,300 girls and women estimated to
have undergone FGM/C prior to immigration had type
III. Of the girls at risk in both the low and high risk sce-
nario, approximately 60 pct. were at risk of infibulation.
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